Literature DB >> 2106982

Node negative breast cancer.

S M O'Reilly1, M A Richards.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2106982      PMCID： PMC1662130          DOI： 10.1136/bmj.300.6721.346

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  20 in total

1.  Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry.

Authors:  G M Clark; L G Dressler; M A Owens; G Pounds; T Oldaker; W L McGuire
Journal:  N Engl J Med       Date:  1989-03-09       Impact factor: 91.245

2.  Short perioperative versus long-term adjuvant chemotherapy.

Authors:  R Nissen-Meyer; H Host; K Kjellgren; B Mansson; T Norin
Journal:  Recent Results Cancer Res       Date:  1985

3.  Interobserver reproducibility of histopathological features in stage II breast cancer. An ECOG study.

Authors:  K W Gilchrist; L Kalish; V E Gould; S Hirschl; J E Imbriglia; W M Levy; A S Patchefsky; D W Penner; J Pickren; J A Roth
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

4.  Proliferative index of breast carcinoma by thymidine labeling: prognostic power independent of stage, estrogen and progesterone receptors.

Authors:  J S Meyer; M Province
Journal:  Breast Cancer Res Treat       Date:  1988-10       Impact factor: 4.872

5.  Progesterone and estrogen receptors as prognostic variables in breast cancer.

Authors:  B H Mason; I M Holdaway; P R Mullins; L H Yee; R G Kay
Journal:  Cancer Res       Date:  1983-06       Impact factor: 12.701

6.  Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer.

Authors:  G Bonadonna; P Valagussa; A Rossi; G Tancini; C Brambilla; M Zambetti; U Veronesi
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

7.  Breast carcinoma cell kinetics, morphology, stage, and host characteristics. A thymidine labeling study.

Authors:  J S Meyer; M U Prey; D S Babcock; R W McDivitt
Journal:  Lab Invest       Date:  1986-01       Impact factor: 5.662

8.  Management and survival of female breast cancer: results of a national survey by the American College of Surgeons.

Authors:  T Nemoto; J Vana; R N Bedwani; H W Baker; F H McGregor; G P Murphy
Journal:  Cancer       Date:  1980-06-15       Impact factor: 6.860

9.  Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update.

Authors:  B Fisher; M Bauer; D L Wickerham; C K Redmond; E R Fisher; A B Cruz; R Foster; B Gardner; H Lerner; R Margolese
Journal:  Cancer       Date:  1983-11-01       Impact factor: 6.860

10.  Relationship between oestrogen-receptor content and histological grade in human primary breast tumours.

Authors:  P V Maynard; C J Davies; R W Blamey; C W Elston; J Johnson; K Griffiths
Journal:  Br J Cancer       Date:  1978-12       Impact factor: 7.640
View more
  6 in total

1.  Node negative breast cancer.

Authors:  J Grogono
Journal:  BMJ       Date:  1990-03-03

2.  Node negative breast cancer.

Authors:  S M O'Reilly; M A Richards
Journal:  BMJ       Date:  1990-05-26

3.  Node negative breast cancer.

Authors:  R W Blamey; C W Elston; I O Ellis; D A Morgan; J L Haybittle
Journal:  BMJ       Date:  1990-04-28

4.  Node negative breast cancer.

Authors:  M D Leslie; E J Maher
Journal:  BMJ       Date:  1990-03-17

5.  Vimentin expression appears to be associated with poor prognosis in node-negative ductal NOS breast carcinomas.

Authors:  W Domagala; J Lasota; A Dukowicz; M Markiewski; G Striker; K Weber; M Osborn
Journal:  Am J Pathol       Date:  1990-12       Impact factor: 4.307

6.  The prognostic significance of DNA flow cytometry in breast cancer: results from 881 patients treated in a single centre.

Authors:  R S Camplejohn; C M Ash; C E Gillett; B Raikundalia; D M Barnes; W M Gregory; M A Richards; R R Millis
Journal:  Br J Cancer       Date:  1995-01       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.